Diabetes, Endocrinology, & Metabolism (DEM)

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Pancreas Transplantation Medicine & Life Sciences
Insulin Medicine & Life Sciences
Insulysin Medicine & Life Sciences
Type 1 Diabetes Mellitus Medicine & Life Sciences
Vitamin D Medicine & Life Sciences
Type 2 Diabetes Mellitus Medicine & Life Sciences
Kidney Transplantation Medicine & Life Sciences
Glucose Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1977 2020

Mechanisms of Antifibrotic Actions of Relaxin in the Liver

Bennett, R. G.

National Institutes of Health

4/1/113/31/20

Project: Research projectNon-HHS Research Projects

Relaxin
Peroxisome Proliferator-Activated Receptors
Hepatic Stellate Cells
Liver
Fibrosis

RELAXIN FAMILY PEPTIDES AND HEPATIC FIBROSIS

Bennett, R. G.

National Institutes of Health

7/5/076/30/11

Project: Research projectResearch Project

Relaxin
Liver Diseases
Fibrosis
Peptides
Liver

Research Output 1987 2019

Quantification of lutein + zeaxanthin presence in human placenta and correlations with blood levels and maternal dietary intake

Thoene, M., Anderson Berry, A. L., Van Ormer, M., Furtado, J., Soliman, G. A., Goldner, W. S. & Hanson, C. K., Jan 1 2019, In : Nutrients. 11, 1

Research output: Contribution to journalArticle

Lutein
zeaxanthin
umbilical cord
lutein
placenta

Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways

Ng, H. H., Shen, M., Samuel, C. S., Schlossmann, J. & Bennett, R. G., Jan 1 2019, (Accepted/In press) In : Molecular and Cellular Endocrinology.

Research output: Contribution to journalArticle

Relaxin
Extracellular Matrix
Fibrosis
Myofibroblasts
Chemical activation
3 Citations

A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin

Lingvay, I., Desouza, C. V., Lalic, K. S., Rose, L., Hansen, T., Zacho, J. & Pieber, T. R., Sep 1 2018, In : Diabetes care. 41, 9, p. 1926-1937 12 p.

Research output: Contribution to journalArticle

Metformin
Type 2 Diabetes Mellitus
Randomized Controlled Trials
Placebos
Exercise